Menezes, P.R., Johnson, S., Thornicroft, G., et al (1996) Drug and Alcohol Problems
among individuals with Severe Mental Illness in South London. British Journal of
Psychiatry, 168, 612-619.
Conclusions The prevalence of substance use problems among people suffering from
severe mental disorders is high, and seems to be associated with greater use of in-patient
services. This is a significant clinical problem, with cost implications. Further
investigation is needed for adequate service provision.
Welch, S.L., Fairburn, C. (1996) Impulsivity or Comorbidity in Bulimia Nervosa A
controlled Study of Deliberate Self-Harm and Alcohol and Drug Misuse in a Community
Sample. British Journal of Psychiatry,169, 451-458.
Conclusion Sampling bias is present in clinic-based studies of comorbidity in bulimia
nervosa. Those with comorbid substance use and deliberate self-harm are probably
heterogeneous in character , and their classification as a subgroup would therefore
Kendler, K.S., Davis, C.G., Kessler, R.C. (1997) The familial aggregation of common
psychiatric and substance use disorders in the National Comorbidity Survey: a family
history study. British Journal of Psychiatry, 170, 541-548.
Conclusions Familial aggregation of common psychiatric and substance use disorders
is substantial in epidemiologic samples. The examined environmental adversities account
for little of the observed parent-offspring transmission of these conditions.
Hall, W., Farrell, M. (1997) Comorbidity of substance misuse and mental disorders
– Editorial. British Journal of Psychiatry, 171, 4-5.
Marsden, J., Gossop, M., Stewart, D., et al (2000) Psychiatric symptoms among clients
seeking treatment for drug dependence. British Journal of Psychiatry, 176, 285-289.
Conclusions Addictions service providers should be vigilant to psychiatric problems
among their clients at intake to treatment. Psychiatric symptoms are linked more
closely to polydrug use than to opiate use in this population.
Soyka, M (2000) Substance misuse, psychiatric disorder and violent and disturbed
behaviour. British Journal of Psychiatry, 176, 345-350.
Conclusion Substance misuse has been shown consistently to be a significant risk
factor for violence and disturbed behaviour. Future research should try to evaluate
possible pharmacological treatment approaches.
Ohberg, A., Vuori, E., Ojanpera, I., et al (1996) Alcohol and Drugs in Suicides.
British Journal of Psychiatry, 169, 75-80.
Conclusions Undertreatment of depression is a challenge for suicide prevention. Those
who commit suicide by antidepressants use their own drugs. Relative suicide risk
for a drug should be considered when choosing treatment for depressive patients.
Vassilas, C.A.., Morgan, H.G. (1997) Suicide in Avon Life stress, alcohol misuse
and use of services. British Journal of Psychiatry, 170, 453-455.
Conclusions Various subgroups of suicide behave differently in the way they seek
and utilise help. The implications of these findings for suicide prevention and service
strategy are discussed.
Neelman, J., Farrell, M. (1997) Suicide and substance misuse - Editorial. British
Journal of Psychiatry,171, 303-304.
Inskip, H.M., Harris, C.E., Barraclough, B. (1998) Lifetime risk of suicide for affective
disorder, alcoholism and schizophrenia. British Journal of Psychiatry, 172, 35-37.
Conclusions The lifetime suicide risk figures often quoted in the literature appear
to be too high.
Oyefeso, A., Ghodse, H., Clancy, C., et al (1999) Suicide among drug addicts in the
UK. British Journal of Psychiatry, 175, 277-282.
Conclusions The findings confirm that addicts are still at higher risk of suicide
than the general population and that prescribed drugs, notably antidepressants and
methadone, influence this heightened risk.
McCloud, A., Barnaby, B., Omu, N., et al (2004) Relationship between alcohol use
disorders and suicidality in a psychiatric population In-patient prevalence study.
British Journal of Psychiatry, 184, 439-445.
Conclusions The AUDIT questionnaire should be incorporated into psychiatric assessments
when risk of self-harm is being evaluated. Further research is warranted to examine
the impact of interventions for alcohol use disorders in psychiatric settings on
self-harm and suicidal ideation.
Cantwell, R., Brewin, J., Glazebrook C., et al (1999) Prevalence of substance misuse
in first episode psychosis. British Journal of Psychiatry, 174, 150-153.
Conclusions This study confirms high rates of substance misuse at onset of psychosis.
There is evidence for an increase in diagnosis of substance-related psychotic disorders
over time. Those most at risk of substance misuse are young males.
Curran, C., Byrappa, N., McBride, A. (2004) Stimulant psychosis: systematic review.
British Journal of Psychiatry, 185, 196-204.
Conclusions Compliance with antipsychotic medication by someone with schizophrenia
will not prevent a relapse or worsening of psychotic symptoms if stimulants are used.
Low-dose antipsychotic treatment may be beneficial in stimulant users, to prevent